This pilot study involving 12 patients exploring intra-tumour heterogeneity of colorectal cancer has demonstrated relative homogeneity of genetic factors (BRAF and KRAS mutations), as well as epigenetic homogeneity (in terms of DNA methylation). This evidence concerns the gene BRAF and colorectal cancer.